Skip to content
10-Q

Quarterly Report

Gene Biotherapeutics, Inc.

0001493152-21-023014

← back to feed
Filed
Sep 17, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2020 · Aug 28, 2021 64.93M sh
Shares Diluted Q2 2020 · Jun 30, 2020 102.35M sh
Shares Diluted Q2 2020 · Jun 30, 2020 58.42M sh
Shares Diluted Q2 2020 · Jun 30, 2019 14.49M sh
Shares Diluted Q2 2020 · Jun 30, 2019 14.48M sh
Operating Cash Flow Q2 2020 · Jun 30, 2020 −$315.34K
Operating Cash Flow Q2 2020 · Jun 30, 2019 −$51.6K
Cash And Equivalents Q2 2020 · Jun 30, 2020 $1.31M
Cash And Equivalents Q2 2020 · Dec 31, 2019 $400
Stockholders Equity Q2 2020 · Jun 30, 2020 −$3.07M
Stockholders Equity Q2 2020 · Dec 31, 2019 −$4.29M
Current Liabilities Q2 2020 · Jun 30, 2020 $4.74M
Current Liabilities Q2 2020 · Dec 31, 2019 $4.76M
Total Liabilities Q2 2020 · Jun 30, 2020 $5.02M
Total Liabilities Q2 2020 · Dec 31, 2019 $4.89M
Current Assets Q2 2020 · Jun 30, 2020 $1.33M
Current Assets Q2 2020 · Dec 31, 2019 $32.8K
Total Assets Q2 2020 · Jun 30, 2020 $1.34M
Total Assets Q2 2020 · Dec 31, 2019 $35.44K
Eps Diluted Q2 2020 · Jun 30, 2020 $0.00
Eps Diluted Q2 2020 · Jun 30, 2020 $0.00
Eps Diluted Q2 2020 · Jun 30, 2019 −$0.02
Eps Diluted Q2 2020 · Jun 30, 2019 −$0.03
Eps Basic Q2 2020 · Jun 30, 2020 $0.03
Eps Basic Q2 2020 · Jun 30, 2020 $0.02
Eps Basic Q2 2020 · Jun 30, 2019 −$0.02
Eps Basic Q2 2020 · Jun 30, 2019 −$0.03
Sga Expense Q2 2020 · Jun 30, 2020 $193.54K
Sga Expense Q2 2020 · Jun 30, 2020 $299.82K
Sga Expense Q2 2020 · Jun 30, 2019 $180.47K
Sga Expense Q2 2020 · Jun 30, 2019 $360.07K
Rd Expense Q2 2020 · Jun 30, 2020 $49.12K
Rd Expense Q2 2020 · Jun 30, 2020 $95.73K
Rd Expense Q2 2020 · Jun 30, 2019 $60.36K
Rd Expense Q2 2020 · Jun 30, 2019 $123.73K
Net Income Q2 2020 · Jun 30, 2020 $435.79K
Net Income Q2 2020 · Jun 30, 2020 $286.03K
Net Income Q2 2020 · Jun 30, 2019 −$226.37K
Net Income Q2 2020 · Jun 30, 2019 −$452.74K
Operating Income Q2 2020 · Jun 30, 2020 $357.34K
Operating Income Q2 2020 · Jun 30, 2020 $204.46K
Operating Income Q2 2020 · Jun 30, 2019 −$240.83K
Operating Income Q2 2020 · Jun 30, 2019 −$483.81K